14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Quercetin enhances survival and axonal regeneration of motoneurons after spinal root avulsion and reimplantation: experiments in a rat model of brachial plexus avulsion

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Brachial plexus avulsion (BPA) physically involves the detachment of spinal nerve roots themselves and the associated spinal cord segment, leading to permanent paralysis of motor function of the upper limb. Root avulsion induces severe pathological changes, including inflammatory reaction, oxidative damage, and finally massive motoneuron apoptosis. Quercetin (QCN), a polyphenolic flavonoid found in abundance in fruit and vegetables, has been reported to possess anti-oxidative, anti-inflammatory, and neuroprotective effects in many experimental models of both central nervous system (CNS) and peripheral nervous system (PNS) disorders. The purpose of this study was to investigate whether QCN could improve motor function recovery after C5–7 ventral root avulsion and C6 reimplantation in a rat model of BPA.

          Methods

          The right fifth cervical (C5) to C7 ventral roots were avulsed followed by re-implantation of only C6 to establish the spinal root avulsion plus re-implantation model in rats. After surgery, rats were treated with QCN (25, 50, and 100 mg/kg) by gavage for 2 or 8 consecutive weeks. The effects of QCN were assessed using behavior test (Terzis grooming test, TGT) and histological evaluation. The molecular mechanisms were determined by immunohistochemistry analysis and western blotting.

          Results

          Our results demonstrated that QCN significantly expedited motor function recovery in the forelimb as shown by the increased Terzis grooming test score, and accelerated motor axon regeneration as evidenced by the ascending number of Fluoro-Ruby-labeled and P75-positive regenerative motoneurons. The raised ChAT-immunopositive and cresyl violet-stained neurons indicated the enhanced survival of motoneurons by QCN administration. Furthermore, QCN treatment markedly alleviated muscle atrophy, restored functional motor endplates in biceps and inhibited the microglial and astroglia activation via modulating Nrf2/HO-1 and neurotrophin/Akt/MAPK signaling pathway.

          Conclusions

          Taken together, these findings have for the first time unequivocally indicated that QCN has promising potential for further development into a novel therapeutic in conjunction with reimplantation surgery for the treatment of BPA. 

          Supplementary Information

          The online version contains supplementary material available at 10.1186/s41232-022-00245-3.

          Highlights

          • Quercetin (QCN) promotes motoneuron survival and accelerates axonal regeneration after brachial plexus root avulsion/re-implantation in rats.

          • QCN improves motor function recovery of the forelimb.

          • QCN exhibits neuroprotective effects via inhibiting neuroinflammation and upregulating the neurotrophins.

          • QCN alleviates the avulsion-induced oxidative damage in rats.

          • QCN inhibits the avulsion-induced neuronal apoptosis in rats.

          • QCN modulates Nrf2/HO-1 and neurotrophin/Akt/MAPK signaling pathways.

          Supplementary Information

          The online version contains supplementary material available at 10.1186/s41232-022-00245-3.

          Related collections

          Most cited references88

          • Record: found
          • Abstract: found
          • Article: not found

          Neurotrophin-regulated signalling pathways.

          Neurotrophins are a family of closely related proteins that were identified initially as survival factors for sensory and sympathetic neurons, and have since been shown to control many aspects of survival, development and function of neurons in both the peripheral and the central nervous systems. Each of the four mammalian neurotrophins has been shown to activate one or more of the three members of the tropomyosin-related kinase (Trk) family of receptor tyrosine kinases (TrkA, TrkB and TrkC). In addition, each neurotrophin activates p75 neurotrophin receptor (p75NTR), a member of the tumour necrosis factor receptor superfamily. Through Trk receptors, neurotrophins activate Ras, phosphatidyl inositol-3 (PI3)-kinase, phospholipase C-gamma1 and signalling pathways controlled through these proteins, such as the MAP kinases. Activation of p75NTR results in activation of the nuclear factor-kappaB (NF-kappaB) and Jun kinase as well as other signalling pathways. Limiting quantities of neurotrophins during development control the number of surviving neurons to ensure a match between neurons and the requirement for a suitable density of target innervation. The neurotrophins also regulate cell fate decisions, axon growth, dendrite growth and pruning and the expression of proteins, such as ion channels, transmitter biosynthetic enzymes and neuropeptide transmitters that are essential for normal neuronal function. Continued presence of the neurotrophins is required in the adult nervous system, where they control synaptic function and plasticity, and sustain neuronal survival, morphology and differentiation. They also have additional, subtler roles outside the nervous system. In recent years, three rare human genetic disorders, which result in deleterious effects on sensory perception, cognition and a variety of behaviours, have been shown to be attributable to mutations in brain-derived neurotrophic factor and two of the Trk receptors.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Trk receptors: roles in neuronal signal transduction.

            Trk receptors are a family of three receptor tyrosine kinases, each of which can be activated by one or more of four neurotrophins-nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and neurotrophins 3 and 4 (NT3 and NT4). Neurotrophin signaling through these receptors regulates cell survival, proliferation, the fate of neural precursors, axon and dendrite growth and patterning, and the expression and activity of functionally important proteins, such as ion channels and neurotransmitter receptors. In the adult nervous system, the Trk receptors regulate synaptic strength and plasticity. The cytoplasmic domains of Trk receptors contain several sites of tyrosine phosphorylation that recruit intermediates in intracellular signaling cascades. As a result, Trk receptor signaling activates several small G proteins, including Ras, Rap-1, and the Cdc-42-Rac-Rho family, as well as pathways regulated by MAP kinase, PI 3-kinase and phospholipase-C-gamma (PLC-gamma). Trk receptor activation has different consequences in different cells, and the specificity of downstream Trk receptor-mediated signaling is controlled through expression of intermediates in these signaling pathways and membrane trafficking that regulates localization of different signaling constituents. Perhaps the most fascinating aspect of Trk receptor-mediated signaling is its interplay with signaling promoted by the pan-neurotrophin receptor p75NTR. p75NTR activates a distinct set of signaling pathways within cells that are in some instances synergistic and in other instances antagonistic to those activated by Trk receptors. Several of these are proapoptotic but are suppressed by Trk receptor-initiated signaling. p75NTR also influences the conformations of Trk receptors; this modifies ligand-binding specificity and affinity with important developmental consequences.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study.

              Flavonoids are polyphenolic antioxidants naturally present in vegetables, fruits, and beverages such as tea and wine. In vitro, flavonoids inhibit oxidation of low-density lipoprotein and reduce thrombotic tendency, but their effects on atherosclerotic complications in human beings are unknown. We measured the content in various foods of the flavonoids quercetin, kaempferol, myricetin, apigenin, and luteolin. We then assessed the flavonoid intake of 805 men aged 65-84 years in 1985 by a cross-check dietary history; the men were then followed up for 5 years. Mean baseline flavonoid intake was 25.9 mg daily. The major sources of intake were tea (61%), onions (13%), and apples (10%). Between 1985 and 1990, 43 men died of coronary heart disease. Fatal or non-fatal myocardial infarction occurred in 38 of 693 men with no history of myocardial infarction at baseline. Flavonoid intake (analysed in tertiles) was significantly inversely associated with mortality from coronary heart disease (p for trend = 0.015) and showed an inverse relation with incidence of myocardial infarction, which was of borderline significance (p for trend = 0.08). The relative risk of coronary heart disease mortality in the highest versus the lowest tertile of flavonoid intake was 0.42 (95% CI 0.20-0.88). After adjustment for age, body-mass index, smoking, serum total and high-density-lipoprotein cholesterol, blood pressure, physical activity, coffee consumption, and intake of energy, vitamin C, vitamin E, beta-carotene, and dietary fibre, the risk was still significant (0.32 [0.15-0.71]). Intakes of tea, onions, and apples were also inversely related to coronary heart disease mortality, but these associations were weaker. Flavonoids in regularly consumed foods may reduce the risk of death from coronary heart disease in elderly men.
                Bookmark

                Author and article information

                Contributors
                huangyanfeng@link.cuhk.edu.hk
                zhangxie1014@163.com
                Eleven.Wong@link.cuhk.edu.hk
                yaoxingdou@126.com
                quchang@scau.edu.cn
                qqxu@link.cuhk.edu.hk
                qiujuyuan@gmail.com
                lisaxian@cuhk.edu.hk
                linzx@cuhk.edu.hk
                Journal
                Inflamm Regen
                Inflamm Regen
                Inflammation and Regeneration
                BioMed Central (London )
                1880-9693
                1880-8190
                1 December 2022
                1 December 2022
                2022
                : 42
                : 56
                Affiliations
                [1 ]GRID grid.10784.3a, ISNI 0000 0004 1937 0482, School of Chinese Medicine, Faculty of Medicine, , The Chinese University of Hong Kong, ; Shatin, N.T., Hong Kong, SAR China
                [2 ]GRID grid.411866.c, ISNI 0000 0000 8848 7685, School of Basic Medical Sciences, Department of Medical Biotechnology, , Guangzhou University of Chinese Medicine, ; Guangzhou, Guangdong People’s Republic of China
                [3 ]GRID grid.411866.c, ISNI 0000 0000 8848 7685, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, ; Guangzhou, People’s Republic of China
                [4 ]GRID grid.9227.e, ISNI 0000000119573309, Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, , Chinese Academy of Sciences, ; Hong Kong Science Park, Shatin, N.T., Hong Kong, SAR China
                [5 ]GRID grid.10784.3a, ISNI 0000 0004 1937 0482, Hong Kong Institute of Integrative Medicine, , The Chinese University of Hong Kong, ; Hong Kong, SAR China
                Author information
                http://orcid.org/0000-0002-5032-0366
                Article
                245
                10.1186/s41232-022-00245-3
                9714227
                36456978
                1682b745-3d79-4312-902f-6737f481e24e
                © The Author(s) 2022

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 19 March 2022
                : 23 November 2022
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2022

                brachial plexus avulsion,quercetin,motoneuron,oxidative damage,inflammatory response

                Comments

                Comment on this article